UNSPSC 51162203: Acetaminophen/diphenhydramine/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162203 Acetaminophen/diphenhydramine/pseudoephedrine is a Commodity code under which state and local governments procure branded and generic OTC cold and allergy relief products for distribution through authorized pharmaceutical wholesalers to state agencies, local health facilities, and participating public bodies. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, has driven recent activity by soliciting manufacturers to supply acetaminophen-based combination products alongside a broader portfolio of generic multi-source pharmaceuticals and OTC items. State and local purchasing under this code centers on establishing fixed-price or competitive-discount supply agreements with manufacturers, requiring compliance with current Good Manufacturing Practices (cGMP), the Drug Supply Chain Security Act (DSCSA), and FDA requirements. Vendors must maintain contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) and submit detailed product specifications including National Drug Codes (NDC), SKUs, UPCs, strength, dosage form, and manufacturing location. Cooperative purchasing alliances and state procurement offices dominate the issuing-body mix, with MMCAP serving multiple states including Minnesota and Oregon under unified supplier frameworks.

The code shows concentrated recent activity centered on the Upper Midwest and Pacific Northwest through the MMCAP cooperative. The Minnesota Multistate Cooperative Purchasing Alliance issued a Request for Proposal (S1070000015802) posted January 20, 2026, with a proposal due date of March 26, 2026, seeking multiple manufacturers to supply generic multi-source pharmaceuticals and OTC products effective July 1, 2026. Evaluation weighs price competitiveness at 75 percent, fixed pricing for contract term at 10 percent, and administrative compliance including EDI capability, cGMP/DSCSA certification, and agreement to a 3 percent administrative fee at 5 percent each. The RFP does not disclose specific award values or budget ranges. Vendors must carry workers' compensation insurance, $5 million commercial general liability per occurrence, $2 million network security and privacy liability, and $2 million professional liability. The contract term extends two years for new responders with optional extensions, while incumbent amendments align with existing expiration dates through June 30, 2028.